Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ENDEP

AMITRIPTYLINE HYDROCHLORIDE

Standard Dose
40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ENDEP is listed in Drugs@FDA under application 085749 (ANDA).

Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ENDEP is listed in Drugs@FDA under application 085749 (ANDA). Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ENDEP (AMITRIPTYLINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline